&w=3840&q=100)
Eli Lilly's weekly insulin efsitora shows positive results in Phase 3
While basal insulin is a long-acting insulin administered once or twice a day, efsitora is designed for once-weekly subcutaneous injection. The company also shared detailed results from the Phase 3 QWINT-1, QWINT-3 and QWINT-4 trials.
The QWINT-1 trial evaluated adults initiating insulin therapy, while QWINT-3 assessed individuals previously using daily basal insulin. QWINT-4 included participants using both basal and mealtime insulin.
'In each study, efsitora met the primary endpoint of non-inferior A1C reduction compared to daily basal insulin,' the company stated.
According to Lilly, in QWINT-1, efsitora reduced A1C by 1.31 per cent compared to 1.27 per cent for insulin glargine at week 52 for the efficacy estimand. In QWINT-3, the drug reduced A1C by 0.86 per cent compared to 0.75 per cent for insulin degludec at week 26.
'In QWINT-4, efsitora reduced A1C by 1.07 per cent, matching insulin glargine's reduction of 1.07 per cent at week 26 for the efficacy estimand,' Lilly added.
The Phase 3 global clinical development programme for the diabetes drug began in 2022 and included over 3,000 participants with type 2 diabetes across four global registration studies.
Commenting on the results, Jeff Emmick, senior vice president of product development at Lilly, said that the once-weekly insulin therapy may offer a significant advancement for people with type 2 diabetes who need insulin, by eliminating over 300 injections a year.
The company added that the drug also has the potential to provide more stable glucose levels—reducing glucose variability—throughout the week.
Eli Lilly now plans to submit the drug to global regulatory agencies for the treatment of type 2 diabetes in adults by the end of 2026.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
19 minutes ago
- Hans India
Shubhanshu Shukla: India's new star
New Delhi: About 41 years after Rakesh Sharma's flight in 1984, India sent an astronaut into space -- Shubhanshu Shukla. Shukla, who became the first Indian to go to the International Space Station (ISS), has emerged as the new star -- also establishing a firm place for India in the global space arena. The 20-day mission, led by private American company Axiom Space, in collaboration with NASA, SpaceX, and other government space agencies, including ISRO, launched to the ISS on June 26. Shukla returned to Earth on Tuesday along with fellow astronauts from the US, Poland, and Hungary aboard SpaceX's Dragon spacecraft "Grace". Lucknow-born Shukla was included in the astronaut selection process by ISRO in 2019 after Prime Minister Narendra Modi in 2018 announced from the Red Fort that a son or daughter of India would go to space very soon. In January 2025, the 39-year-old astronaut was selected as the pilot for the Ax-4 mission -- a collaborative mission between NASA and ISRO. The IAF officer became the youngest astronaut-designate under India's Gaganyaan mission -- the country's first human spaceflight mission. Speaking to IANS in March, Shukla said he hopes to use his 'journey to inspire this entire generation to pursue their careers in the field of space,' as he 'was extremely inspired and motivated' by Rakesh Sharma. On the Ax-4 mission, Shukla served as the pilot alongside Commander Peggy Whitson of the US. 'During the transit journey, I'm going to be acting as the mission pilot, so I will be working alongside the commander of the vehicle, managing the systems, navigating the vehicle, and looking at all the data that is available, and if required, intervening and, interacting with the systems, if something was to go wrong or there was a need for a manual intervention,' Shukla told IANS. On the ISS, Shukla conducted seven pioneering experiments related to food and space nutrition that aimed to enhance understanding of sustainable life-support systems, a crucial aspect of future long-duration space travel. 'Experiments on Indian strain of tardigrades, myogenesis, sprouting of methi and moong seeds, cyanobacteria, microalgae, crop seeds, and voyager display have been completed as planned,' ISRO said. Shukla's mission is not only an inspiration for billions of Indians but also a key stepping stone for India's Gaganyaan human spaceflight mission, slated for 2027.
The Hindu
22 minutes ago
- The Hindu
Two-day academic fest in Puducherry draws contestants from 35 medical colleges
Students from 35 medical colleges across the country participated in the recently-concluded inter-collegiate academic festival hosted by the Pondicherry Institute of Medical Sciences (PIMS). 'Equinox'25' featured a diverse range of academic activities, such as workshops (Surgery, ECG, Orthopaedics, Emergency medicine, etc), quiz contest, clinicopathologic correlation, clinical case presentations, and research paper presentations. These events were curated to enhance clinical reasoning, encourage scientific discussion, and build essential academic skills among participants, a press note said. Satish Kumar Amarnath, renowned Bengaluru-based microbiologist was the key speaker and Mathew Cherian, interventional radiologist from Kovai Medical Hospital, the chief guest at the inaugural ceremony. The two-day event was organised by a team led by Renu G'boy Varghese, Director-Principal of PIMS, Nayyar Iqbal, organising chairperson, Nishanth Rajan, Vice-Principal and Divyansh Phartyal and Lokshana, students who served as academic secretaries.
Economic Times
24 minutes ago
- Economic Times
Astronaut Shubhanshu Shukla back on terra firma after 18-day space expedition
Agencies Axiom-4 mission crew members: Commander Peggy Whitson. Pilot Shubhanshu Shukla 'Shux', Mission Specialist Sławosz 'Suave' Uznański-Wiśniewski, and Mission Specialist Tibor Kapu along with Expedition 73 crew.(Source: After 18 days in space, Group Captain and astronaut Shubhanshu Shukla experienced gravity again on Tuesday. Stepping out of the Dragon capsule with a grin and the Indian flag on his shoulder, Shukla, or Shux, became the second Indian to travel to space and the first to enter the International Space Station (ISS) as part of the Axiom-4 (Ax-4) mission. The SpaceX Dragon capsule carrying pilot Shukla and three other crew members, mission commander Peggy Whitson and project astronauts Tibor Kapu and Sławosz Uznański-Wiśniewski, splashed down off the coast of San Diego, California, at approximately 3:02 pm IST on July 15. The return journey from the ISS to splashdown lasted 22.5 hours. The Ax-4 mission, seen as a precursor to the Indian Space Research Organisation's (ISRO) upcoming Gaganyaan human spaceflight programme, saw Shukla conduct seven microgravity experiments aboard the ISS, a first for an Indian national. Prime Minister Narendra Modi, welcoming Shukla's return to earth, said, 'As India's first astronaut to have visited the International Space Station, he has inspired a billion dreams through his dedication, courage, and pioneering spirit.' The PM, who also holds the portfolio of space, added that the mission's success marked 'another milestone towards our own Human Space Flight Mission - Gaganyaan.'Shukla, along with his crew members, will spend seven days in a rehabilitation programme. Medical evaluations will be conducted, covering physical fitness, balance, reflexes, cardiovascular functions, and immune response. The astronauts will be debriefed about the mission experience and research experiments. The data will help the partner nations plan future collaborative space missions. Experts say extended exposure to microgravity can lead to temporary bone loss, muscle weakening, and changes in how fluids move through the body. This can affect everything from blood circulation to organ function. NASA specialists noted that astronauts often return with symptoms like swollen faces, thinner legs, changes in vision, and even a slight increase in height during their time in orbit. ISRO, in a statement earlier, said, 'Gaganyatri Shubhanshu Shukla has successfully completed all seven microgravity experiments and other planned activities, achieving significant milestones in the mission.'The space agency said all planned experiments were successfully completed. These included studies on Indian strains of tardigrades (to observe how microorganisms behave in microgravity), myogenesis (muscle cell development), sprouting of methi and moong seeds, performance of cyanobacteria and microalgae (photosynthetic microbes) and the response of crop seeds in space were recorded. ISRO also sent a 'Voyager Display' experiment, which tested how electronic screens function in microgravity. It was named after NASA's Voyager 1 and 2 to the media, Jitendra Singh, minister of state for science and technology, said Shux will hold discussions with ISRO experts and undergo debriefings with Axiom Space, SpaceX, and NASA. He added that the experiments conducted will be of relevance for the whole world. The astronaut is expected to be back in New Delhi on August 17."Bharat today finds an enduring Space in the world of Space!" Singh wrote on Ax-4 was launched from Kennedy Space Centre on June 25, during which astronauts from India, Hungary, and Poland, along with NASA veteran Whitson, conducted about 60 scientific experiments. Elevate your knowledge and leadership skills at a cost cheaper than your daily tea. Rumblings at the top of Ola Electric The hybrid vs. EV rivalry: Why Maruti and Mahindra pull in different directions. What's best? How Safexpress bootstrapped its way to build India's largest PTL Express business Zee promoters have a new challenge to navigate. And it's not about funding or Sebi probe. Newton vs. industry: Inside new norms that want your car to be more fuel-efficient Stock Radar: UltraTech Cements hit a fresh record high in July; what should investors do – book profits or buy the dip? F&O Radar | Deploy Bear Put Spread in Nifty to gain from index correction Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports Plus
